Association of Cognitive Impairment with Clinical Variables in Migraine Patients
Abstract
Background: This study explores the relationship between migraine and cognitive impairment, aiming to recognize deficits during ictal and interictal phases.This study examines how migraine frequency and severity affect understanding and evaluates the competence of present treatments in reducing these impairments.Understanding these relations may help improve management approaches and improve the quality of life for migraine sufferers.This study aims to measure the prevalence of cognitive impairment in migraine patients and discover its association with clinical variables, including migraine severity, duration, psychological factors, and treatment outcomes.Methods: This cross-sectional observational study included 100 migraine patients aged 18 to 60 years, diagnosed per ICHD-3 criteria.Participants underwent assessments using MoCA, MIDAS, and HADS scales, alongside serum vitamin B12 and TSH testing.Cognitive impairment was defined as a MoCA score 0.05).However, 66% showed cognitive improvement after 3 months of treatment (p=0.002),suggesting potential reversibility.Conclusion: Cognitive impairment was present in 19.6% of migraine patients, with no significant correlation to clinical variables.Effective treatment improved cognition, highlighting the need for holistic migraine management.
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause. Reported size: 100 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.